StockIQpro
NASDAQ:BTMD

biote Corp.

biote Corp.'s revenue fell 2.5% in fiscal 2025 to $192.2M while operating margin rose to 18.5%. Free cash flow was $30.2M, 15.7% of revenue, and the diluted share count rose 7.0%.Summary generated from biote Corp.'s SEC filings. Latest annual report filed Mar 13, 2026.

Revenue (FY25)$192.2M
Revenue growth−2.5%
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating margin18.5%
Net margin14.1%
ROICn/a
Return on equityn/a
Debt / equityn/a
Free cash flow$30.2M
FCF margin15.7%
Share count change+7.0%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue139165185197192
Operating income35−61293236
Net income11−13327
Free cash flow32−9273930

Recent filings

From SEC EDGAR

Peers

Medicinal chemicals & botanical products